Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.11, 2005-11, pp. : 1385-1409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2433-2455

Bentham Science Publishers

Access to resources Recommend Favorite

The Multifactorial Nature of Alzheimer’s Disease for Developing Potential Therapeutics

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1745-1770

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease

By Van Dam Debby Coen Katrien De Deyn Peter

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 37-43

Springer Publishing Company

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimers Disease

By McGeer P.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

GSK-3 inhibitors and their potential in the treatment of Alzheimer’s disease

By Kypta Robert M

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1315-1331

Informa Healthcare

Access to resources Recommend Favorite